Liraglutide ntụ ntụ
bụ ọcha na-acha ọcha na-acha ọcha crystalline ntụ ntụ, na aha kemịkal L-lysine-dipeptidyl glucagon-dị ka peptide-1 agonist receptor. Usoro ihe omimi ya bụ C172H265N43O51, na ịdị arọ ya bụ 3751.19 g/mol. Liraglutide nwere obere solubility na mmiri, mana enwere ike ịgbaze ya na ihe mgbaze kwesịrị ekwesị. Ọdịdị kemịkal ya na ihe anụ ahụ na-eme ka ọ dị mma maka injection iji mezuo ebumnuche ọgwụgwọ ọrịa shuga na oke ibu.
Product aha: |
Liraglutide |
CAS Mba: |
204656-20-2 | |
Ụbọchị mmepụta: 2024,05.14 |
Ụbọchị nyocha: 2024,05.14 |
Ụbọchị mkpesa: 2024.05.15 |
Ụbọchị nchekwa: 2026.05.14 |
|
Nkebi |
Nkọwapụta |
IHE |
||
e ji mara |
White ma ọ bụ na-acha ọcha ntụ ntụ |
Kwuru |
||
Identification |
HPLC RT |
Kwuru |
||
Ịdị ọcha (HPLC) |
≥98% |
99.35% |
||
mmiri |
8.0% ~ 11.0% |
10.0% |
||
Ihe nkwụsị nke ala |
||||
methanol |
≤0.3% |
ND |
||
isopropanol |
≤0.5% |
ND |
||
Methylene chloride |
≤0.06% |
ND |
||
N, N-Dimethylformamide |
≤0.088% |
ND |
||
mmechi |
||||
mmechi |
Nsonaazụ ule na-agbaso ihe achọrọ nke nkọwapụta ụlọ. |
|||
Nkwakọ ngwaahịa na nchekwa |
Na-echekwa na okpomọkụ nke 2 ~ 8C, na-echebe site na ìhè. |
bụ ọgwụ a na-eji agwọ ọrịa shuga, a na-ejikwa agwọ ndị nwere oke ibu ma ọ bụ oke ibu. Ọ bụ nke otu ọgwụ a na-akpọ glucagon-dị ka peptide-1 agonists, nke nwere ike inye aka belata ọkwa shuga dị n'ọbara, belata ibu, ma melite mmepụta insulin. A na-enyekarị Liraglutide dị ka ịgba ntụtụ, mana enwere ike ịnye ya dị ka ntụ ntụ soluble.
Ịgwọ ọrịa shuga mellitus
Usoro onunu ogwu na ojiji nke Liraglutide nwere ike ịdị iche dabere na ọnọdụ ahụike a na-agwọ. Agbanyeghị, ebe a bụ ụfọdụ ntuziaka izugbe:
Maka ọgwụgwọ ụdị ọrịa shuga 2:
Usoro mmalite mmalite bụ 0.6 mg otu ugboro kwa ụbọchị, nke a na-enye ya site na ntụtụ subcutaneous.
Mgbe otu izu gasịrị, a na-abawanye dose ahụ ruo 1.2 mg otu ugboro kwa ụbọchị.
Ụfọdụ ndị ọrịa nwere ike ịchọ mmezi usoro onunu ogwu ọzọ, ihe ruru 1.8 mg otu ugboro kwa ụbọchị.
Maka ọgwụgwọ oke ibu:
Usoro akwadoro maka ọgwụgwọ oke ibu bụ 3 mg otu ugboro kwa ụbọchị, nke a na-enye ya site na ntụtụ subcutaneous.
Ọ dị mkpa ịgbaso ntuziaka usoro onunu ogwu nke onye na-ahụ maka ahụike gị nyere. A na-enyekarị Liraglutide n'onwe ya dị ka ntụtụ subcutaneous n'ime afọ, apata ụkwụ, ma ọ bụ ogwe aka elu. Ekwesịrị ịtụgharị saịtị ịgba ntụtụ ka ịzenarị ahụ erughị ala na lipodystrophy mpaghara.
At Salispharm, Anyị na-agba mbọ ịkwado ụkpụrụ kachasị mma na nchekwa na ngwaahịa anyị. Anyị Liraglutide ntụ ntụ. na-ezute ụkpụrụ na asambodo dị mma ndị a:
ejikọtara nke ọma iji kwe nkwa ntụkwasị obi na ịdị mma n'oge njem.
Kwesịrị ekwesị maka nkwakọ ngwaahịa site na 1kg ruo 25kg
A na-etinyekarị ihe nlele n'ime akpa nkwakọba ihe dị n'ime ejiri kpuchido ịdịmma na nchekwa nke ihe nlele ahụ. Akpa nkwakọ ngwaahịa dị n'ime na-abụkarị akpa foil aluminum ma ọ bụ akpa rọba, nke nwere ike kewapụ ikuku na mmiri nke ọma ma nọgide na-enwe nkwụsi ike nke ihe nlele.
Kwesịrị ekwesị maka nkwakọ ngwaahịa na mg
Mpempe akwụkwọ API nwere ihe ejiri mechiri emechi iji hụ na API adịghị emerụ ma ọ bụ mebie ya n'oge nchekwa na njem, si otú a na-ahụ na ọ dị mma nke API. Mpempe akwụkwọ ndị ahụ na-enwekarị akara nwere ozi gbasara API, dị ka nọmba ogbe, nkọwapụta, ụbọchị mmepụta, ụbọchị ngafe, wdg.
Maka ojiji na ihe karịrị 25kg
Ogwe kaadiboodu dị ọkụ, siri ike na gburugburu ebe obibi, ma nwee ike chebe ọdịnaya nke ọma site na mmebi na mmetọ. Igwe kaadiboodu na-enwekarị mkpuchi iji kwe ka emechi ma mechie ya iji hụ na nchekwa nke ọdịnaya n'oge njem na nchekwa.
Maka ajụjụ ndị ọzọ ma ọ bụ ịrịọ nkwupụta maka Liraglutide. na ndị ọzọ na-emepụta ọgwụ akụrụngwa, Ọ bụrụ na ị chọrọ ịzụ Liraglutide ntụ ntụ.,biko nweere onwe gị ịkpọtụrụ anyị sasha_slsbio@aliyun.com.Anyị raara onwe anyị nye iji gboo mkpa gị ahaziri iche na ịnye azịza a pụrụ ịdabere na ya maka ihe nrụpụta ọgwụ gị chọrọ.
Mgbe a bịara na isi mmalite akụrụngwa akụrụngwa.dị kaLiraglutide, Salispharm pụtara dị ka nhọrọ kacha amasị maka ndị na-azụ ahịa nwere nghọta zuru ụwa ọnụ. Nke a bụ ihe kpatara ya:
1. Ònye ka anyị bụ?
Anyị dabere na Xian, China, malite na 2020, na-ere ahịa ụlọ (45.00%), Western Europe (10.00%), Eastern Asia (10.00%), North America (10.00%), Africa (5.00%), Central America (5.00%). 5.00%), Ndịda Ebe Ọwụwa Anyanwụ Eshia (5.00%), South America (5.00%), Mid East (51%). Enwere ihe dị ka mmadụ 100-XNUMX na ụlọ ọrụ anyị.
2. Olee otú anyị pụrụ ekwe nkwa mma?
Mgbe niile tupu mmepụta sample tupu uka mmepụta; Nyocha ikpeazụ mgbe niile tupu mbupu;
3. Kedu ihe ị nwere ike ịzụta n'aka anyị?
Ihe na-acha ọcha na-acha ọkụ ọkụ, pigmenti na akwa, ndị na-ahụ maka ọgwụ, ihe ịchọ mma agba, adịghị ọcha ọgwụ na ngwaahịa ndị ọzọ.
4.Gịnị mere ị ga-eji zụta n'aka anyị ọ bụghị site na ndị ọzọ na-eweta?
A na-ebupụ ngwaahịa RD & ahịa ahịa na Europe, North na South America, Middle East, Asia Pacific na Africa, iji guzobe mmekọrịta dị ogologo ma kwụsie ike na ndị ahịa n'ụwa.
5.What ọrụ anyị nwere ike inye?
Usoro nnyefe anabatara: FOB, CFR, CIF, EXW, FAS, CIP, CPT, DDU, Nnyefe Express; Ego ịkwụ ụgwọ anabatara:USD,EUR,CNY; Ụdị ịkwụ ụgwọ anabatara: T/T,L/C,D/PD/A,Western Union,Cash; Asụsụ: Bekee, Chinese.